{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:06:10Z","timestamp":1789146370002,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117199","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:23:44Z","timestamp":1785403424000},"page":"117199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Curdlan alleviates non-alcoholic fatty liver disease by enriching butyrate-producing gut microbiota-liver axis"],"prefix":"10.1016","volume":"187","author":[{"given":"Xiaoying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.intimp.2026.117199_bb0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.intimp.2026.117199_bb0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.117199_bb0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0025","doi-asserted-by":"crossref","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated Steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.intimp.2026.117199_bb0030","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0035","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1038\/s41467-022-34671-1","article-title":"Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism","volume":"13","author":"Lei","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117199_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117199_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117199_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093066","article-title":"The molecular and mechanistic insights based on gut-liver Axis: nutritional target for non-alcoholic fatty liver disease (NAFLD) improvement","volume":"21","author":"Ji","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0055","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41467-017-02325-2","article-title":"Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117199_bb0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1210\/jc.2016-2669","article-title":"Antiinflammatory and ROS suppressive effects of the addition of Fiber to a high-fat high-calorie meal","volume":"102","author":"Ghanim","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.117199_bb0065","article-title":"Lentinan supplementation protects the gut-liver axis and prevents steatohepatitis: the role of gut microbiota involved","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Nutr."},{"issue":"7","key":"10.1016\/j.intimp.2026.117199_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.117199_bb0075","doi-asserted-by":"crossref","first-page":"1037696","DOI":"10.3389\/fnut.2022.1037696","article-title":"Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: a systematic review","volume":"9","author":"Amiri","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117199_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124259","article-title":"Biopharmaceutical applications of microbial polysaccharides as materials: a review","volume":"239","author":"Song","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117199_bb0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/bm500038g","article-title":"Properties, chemistry, and applications of the bioactive polysaccharide curdlan","volume":"15","author":"Zhang","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.intimp.2026.117199_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.646988","article-title":"Therapeutic and industrial applications of Curdlan with overview on its recent patents","volume":"8","author":"Chaudhari","year":"2021","journal-title":"Front. Nutr."},{"issue":"4","key":"10.1016\/j.intimp.2026.117199_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041305","article-title":"Dietary Curdlan enhances Bifidobacteria and reduces intestinal inflammation in mice","volume":"13","author":"Rahman","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.117199_bb0100","article-title":"Curdlan intake changes gut microbial composition, short-chain fatty acid production, and bile acid transformation in mice","volume":"27","author":"Watanabe","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.intimp.2026.117199_bb0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fnins.2020.00384","article-title":"Curdlan prevents the cognitive deficits induced by a high-fat diet in mice via the gut-brain Axis","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ajg.2013.95","article-title":"The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence","volume":"108","author":"Oddy","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","article-title":"Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease","volume":"13","author":"Stoeva","year":"2021","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200597","article-title":"Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41\/43-CaMKII\/HDAC1-CREB pathway","volume":"67","author":"Zheng","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0125","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/resp.12985","article-title":"Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice","volume":"22","author":"Juan","year":"2017","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cmet.2024.03.003","article-title":"Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity","volume":"36","author":"Tong","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.117199_bb0140","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","article-title":"Hepatic Kr\u00fcppel-like factor 16 (KLF16) targets PPAR\u03b1 to improve steatohepatitis and insulin resistance","volume":"70","author":"Sun","year":"2021","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.intimp.2026.117199_bb0145","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1007\/s00216-021-03785-8","article-title":"Quantitative analysis of short-chain fatty acids in human plasma and serum by GC-MS","volume":"414","author":"Yao","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.intimp.2026.117199_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jnutbio.2018.08.016","article-title":"Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice compared to diet-resistant mice","volume":"65","author":"Zhang","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2026.117199_bb0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117199_bb0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12967-022-03540-2","article-title":"Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117199_bb0170","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-024-03165-6","article-title":"Western diets and chronic diseases","volume":"30","author":"Adolph","year":"2024","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.117199_bb0175","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s42255-025-01356-0","article-title":"Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis","volume":"7","author":"Jung","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.intimp.2026.117199_bb0180","doi-asserted-by":"crossref","first-page":"1134661","DOI":"10.3389\/fimmu.2023.1134661","article-title":"NF-\u03baB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells","volume":"14","author":"Mussbacher","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0185","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2026.117199_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/db12-0135","article-title":"Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-kappaB-mediated PTP1B expression","volume":"62","author":"Yu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2026.117199_bb0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbi.2023.11.016","article-title":"Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis","volume":"115","author":"Zheng","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s42255-024-01177-7","article-title":"Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis","volume":"7","author":"Zhang","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.intimp.2026.117199_bb0205","doi-asserted-by":"crossref","unstructured":"Y. P. Zhuang, Y. T. Zhang, R. X. Zhang, H. J. Zhong, X. X. He, The gut-liver axis in nonalcoholic fatty liver disease: association of intestinal permeability with disease severity and treatment outcomes, Int. J. Clin. Pract. 2022(2022) 4797453.","DOI":"10.1155\/2022\/4797453"},{"key":"10.1016\/j.intimp.2026.117199_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.930928","article-title":"Lactic acid bacterial supplementation ameliorated the lipopolysaccharide-induced gut inflammation and Dysbiosis in mice","volume":"13","author":"Bhatia","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117199_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.117199_bb0220","article-title":"The microbiota and it\u2019s correlation with metabolites in the gut of mice with nonalcoholic fatty liver disease","volume":"12","author":"Gu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117199_bb0225","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117199_bb0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/JPER.22-0205","article-title":"Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism","volume":"94","author":"Lin","year":"2023","journal-title":"J. Periodontol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117199_bb0235","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10620-018-5313-z","article-title":"Proinflammatory sulfur-reducing Bacteria are more abundant in colonic biopsies of patients with microscopic colitis compared to healthy controls","volume":"64","author":"Millien","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2026.117199_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091916","article-title":"Lactiplantibacillus plantarum-12 alleviates inflammation and Colon Cancer symptoms in AOM\/DSS-treated mice through modulating the intestinal microbiome and metabolome","volume":"14","author":"Ma","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.117199_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.788576","article-title":"Gut microbiota and serum metabolic signatures of high-fat-induced bone loss in mice","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117199_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2023","journal-title":"Intern. Emerg. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-022-00486-0","article-title":"Exosomal CagA from helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression","volume":"14","author":"Guo","year":"2022","journal-title":"Gut Pathogens"},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0260","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1499-3872(11)60083-0","article-title":"Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation","volume":"10","author":"Ren","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: diet, health and the gut microbiota","volume":"16","author":"Zmora","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.117199_bb0270","doi-asserted-by":"crossref","unstructured":"C. Matthies, S. Evers, W. Ludwig, B. Schink, Anaerovorax odorimutans gen. nov., sp. nov., a putrescine-fermenting, strictly anaerobic bacterium, Int. J. Syst. Evol. Microbiol. 50 Pt 4(2000) 1591\u20131594.","DOI":"10.1099\/00207713-50-4-1591"},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0275","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/s41598-018-21241-z","article-title":"The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2026.117199_bb0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0285","doi-asserted-by":"crossref","first-page":"15876","DOI":"10.1038\/s41598-017-16189-5","article-title":"Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome","volume":"7","author":"Nishitsuji","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0290","doi-asserted-by":"crossref","first-page":"22385","DOI":"10.1038\/s41598-024-72909-8","article-title":"Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117199_bb0295","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12072-023-10596-9","article-title":"Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study","volume":"18","author":"Jin","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.intimp.2026.117199_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112404","article-title":"Female C57BL\/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D(2) synthase","volume":"595","author":"Islam","year":"2025","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10170","key":"10.1016\/j.intimp.2026.117199_bb0305","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","article-title":"Carbohydrate quality and human health: a series of systematic reviews and meta-analyses","volume":"393","author":"Reynolds","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.intimp.2026.117199_bb0310","article-title":"Decreasing the crystallinity and degree of polymerization of cellulose increases its susceptibility to enzymatic hydrolysis and fermentation by colon microbiota","volume":"12","author":"Thielemans","year":"2023","journal-title":"Foods (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117199_bb0315","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2026.117199_bb0320","series-title":"EFSA panel on food additives and Flavourings (FAF). In: 2019","author":"Younes","year":"2019"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:09:16Z","timestamp":1789142956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S1567576926010453"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117199","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curdlan alleviates non-alcoholic fatty liver disease by enriching butyrate-producing gut microbiota-liver axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117199"}}